Wei-Ru Xu
Impact in
-
- Acupuncture Treatment Research Studies
- Complementary and Alternative Medicine Studies
- Pharmacology top 10%
- Plant-based Medicinal Research
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Cancer Cells and Metastasis 2
- Lung Cancer Research Studies 2
-
- Acupuncture Treatment Research Studies 4
- Co-authors
- Guowang Yang (7 shared papers)Xiaomin Wang (7 shared papers)Mingwei Yu (7 shared papers)Xin Qi (3 shared papers)Xiaoyun Zhu (3 shared papers)Wei Hou (2 shared papers)Hongsheng Lin (2 shared papers)Ying Zhang (2 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Trials (2 papers)Medicine (1 paper)Medical Oncology (1 paper)The Breast (1 paper)
- Partner nations
- China
In The Last Decade
Wei-Ru Xu
14 papers receiving 319 citations
Peers
Comparison fields: 5 of 66
- Complementary and alternative medicine 77
- Pharmacology 50
- Oncology 124
- Toxicology 12
- Pharmacology 48
Countries citing papers authored by Wei-Ru Xu
This map shows the geographic impact of Wei-Ru Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Ru Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Ru Xu more than expected).
Fields of papers citing papers by Wei-Ru Xu
This network shows the impact of papers produced by Wei-Ru Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Ru Xu. The network helps show where Wei-Ru Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei-Ru Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 65 | |
| 2 | 2011 | 57 | |
| 3 | 2015 | 45 | |
| 4 | 2014 | 37 | |
| 5 | [Clinical randomized controlled study on acupuncture for treatment of peripheral neuropathy induced by chemotherapeutic drugs]. | 2010 | 33 |
| 6 | 2020 | 31 | |
| 7 | 2017 | 17 | |
| 8 | 2017 | 12 | |
| 9 | 2011 | 11 | |
| 10 | 2017 | 9 | |
| 11 | 2011 | 4 | |
| 12 | 2014 | 3 | |
| 13 | [Oxymatrine Diminished the Side Population and Inhibited Wnt/p-catenin Signaling Pathway in MCF- 7 Breast Cancer Cells]. | 2016 | 1 |
| 14 | [Progress on the treatment of chemotherapy-induced peripheral neuropathy by Chinese and Western medicine]. | 2008 | 1 |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Wei-Ru Xu
Wei-Ru Xu is a scholar working on Oncology, Complementary and alternative medicine, Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 16 papers that have together received 326 indexed citations. Recurring topics across this work include Acupuncture Treatment Research Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Treatments and Mutations (3 papers), Estrogen and related hormone effects (3 papers), Plant-based Medicinal Research (3 papers), Cancer Cells and Metastasis (2 papers), Epigenetics and DNA Methylation (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Complementary and alternative medicine (77 citations), Pharmacology (50 citations), Oncology (124 citations), Toxicology (12 citations) and Pharmacology (48 citations). Wei-Ru Xu has collaborated with scholars based in China. Frequent co-authors include Guowang Yang, Xiaomin Wang, Mingwei Yu, Xin Qi, Xiaoyun Zhu, Wei Hou, Hongsheng Lin, Ying Zhang, Baojin Hua and Wei Hou. Their work appears in journals such as Frontiers in Oncology, Trials, Medicine, Medical Oncology and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.